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THE MAIN CAUSES OF MORBIDITY and mortality in cystic fibrosis (CF) are chronic lung infection and deteriorating lung function (65, 68) . CF is caused by mutations in the cystic fibrosis transmembrane conductance regulator protein (CFTR) gene, which encodes a cAMP-regulated chloride channel expressed in epithelial cells in the airways, pancreas, intestine, testis, and other tissues (68) . A major unresolved question in CF biology, with considerable importance for development of new therapies, is how CFTR mutations cause lung disease. Some proposed mechanisms include defective organellar acidification, impaired airway submucosal gland function, abnormal immune cell response, and altered airway surface liquid (ASL) composition and volume (4, 17, 50, 68, 81) . This review is focused on the proposed impairment of organellar acidification in CF. Defective organellar acidification has been an attractive hypothesis because it can explain a wide range of cellular and organ pathologies associated with CF. However, because pH regulation in the secretory and endocytic pathways is crucial to numerous cell functions, including protein processing, degradation, and sorting, signal transduction, and metabolism (26, 33, 36, 67, 75, 80) , its impairment might be predicted to have a severe phenotype. Nonetheless, for nearly two decades, the defective organellar acidification hypothesis, in various forms, has emerged as a recurring theme to account for CF lung pathology and so warrants serious consideration. Acidification of intracellular organelles, such as endosomes, lysosomes, and Golgi, requires active proton pumping into the organelle lumen by the vacuolar proton pump (H ϩ -ATPase), a bafilomycin-sensitive, electrogenic pump that produces an interior-positive membrane potential (22, 52, 56, 76) . To maintain electroneutrality, as needed to allow proton transport into the organelle lumen, movement of each proton into the organelle lumen must be accompanied by net inward movement of an anion or outward movement of a cation. Substantial evidence implicates chloride entry as the primary "shunt" mechanism allowing organellar acidification (reviewed in Refs. 52, 56) . As shown in Fig. 1A , chloride entry could involve transport through a chloride channel, such as CFTR, or through a proton-coupled ClC-type chloride channel. Alternatively, proton entry could be accompanied, in principle, by potassium exit through a potassium channel. Bicarbonate cannot provide the shunt pathway because bicarbonate entry is equivalent to proton exit, and sodium is unlikely to provide a useful shunt pathway because of its low concentration in cytoplasm. Other intracellular ionic species are membraneimpermeable or present at very low concentrations. In some cell types, there is evidence for involvement of Na ϩ -K ϩ -ATPase and Na ϩ -H ϩ -exchangers (NHEs) in the regulation of endosomal pH (5, 9, 23, 24) , although there are at present no data on whether these proteins play a role in organellar acidification in epithelial cells. Another factor governing organellar acidification is the buffer capacity of the organelle lumen, largely arising from proteins carrying negative charge, which dictates the number of added protons needed to reduce pH. Figure 1B summarizes approximate pH and chloride concentrations in various organelles.
Proof of involvement of CFTR in organellar acidification and abnormal organellar pH in CF mandates fulfillment of a series of requirements. CFTR should be expressed and functional in organelle(s) where it regulates pH. Organellar pH should be abnormal in appropriate CF cells as measured by well-validated methods such as ratio imaging microscopy of organelle-targeted fluorescent pH indicators (58) . Finally, comparisons between non-CF and CF cells are best done in native or primary cultures of relevant human tissues, with appropriate caveats recognized for studies done on tissues from mice, where CF lung disease does not develop, or from transfected cells models that suffer from clonal variations, consequences of CFTR overexpression, and, in some models, the expression of wild-type CFTR on a background of mutant CFTR protein.
DEFECTIVE ORGANELLAR ACIDIFICATION IN CF: THE ORIGINAL HYPOTHESIS
In 1991, Barasch and colleagues (2) reported evidence for CFTR as a determinant of organellar acidification. Organellar pH was estimated in immortalized epithelial cells derived from CF nasal polyps and non-CF trachea from organellar uptake of the weak base 3-(2,4-dinitroanilino)-3Ј-amino-N-methyldipropylamine (DAMP) and by spectrofluorimetric methods. In CF cells, modest increases in pH (ϳ0.2 to 0.5 pH units) were reported in the trans-Golgi and endosomes (mannose 6-phosphate receptor-positive organelles by immunoelectron microscopy and a "light" fraction by differential centrifugation). Barasch et al. (2) also reported that membrane chloride conductance limited organellar acidification in isolated endosomes, but not lysosomes, from CF cells.
The consequence of Golgi and endosomal alkalinization in CF cells were proposed to include decreased sialyltransferasemediated modification of proteins and lipids and misprocessing of cargo molecules endocytosed by receptor-mediated pathways (Fig. 2) . The defective organellar acidification hypothesis was immediately compelling because loss-of-function CFTR mutations could account for many of the observed abnormalities in CF. For example, decreased sialyltransferase activity elevated asialoganglioside levels, a potential Pseudomonas binding site (10) .
EVIDENCE AGAINST DEFECTIVE ORGANELLAR ACIDIFICATION IN CF
Despite the initial excitement about a possible link relating CFTR loss-of-function to CF disease, subsequent studies from different laboratories challenged the involvement of CFTR in organellar acidification. Lukacs et al. (46) used spectrofluorimetric measurements to investigate the determinants of endosomal acidification in fibroblasts expressing physiologically appropriate levels of CFTR by transfection. Although CFTR activity was demonstrable in endosomes, as evidenced by forskolin-dependent increase in protonophore-induced endosomal alkalinization in whole cells and isolated endosomes, the intrinsic anion conductance of endosomal membranes was not a limiting factor for acidification. Using similar experimental approaches, the conclusions that CFTR is active in endosomal membranes and that anion conductance does not limit endosomal acidification were confirmed in T84 colonic epithelial cells, which express endogenous CFTR, and in CFTR-transfected fibroblasts (3, 72) . Ratio imaging of pH-sensitive fluorophores revealed no difference in endosomal pH in pancreatic epithelial cells derived from a homozygous ⌬F508-CFTR source vs. genetically matched cells transfected with wild-type CFTR (18) . Several of these studies addressed the activation status of CFTR in endosomal membranes. Forskolin stimulation did not alter, or mildly alkalinized, endosomal pH in transfected fibroblasts (46, 72) , T84 cells (3), and pancreatic epithelial cells (18) , contrary to the prediction that CFTR expression and activation would increase endosomal acidification and to the assumption that CFTR is active in endosomal membranes.
Initial measurements of pH in the secretory pathway made using a microinjected liposome delivery method to introduce fluorescent pH indicators into the trans-Golgi showed no CFTR-dependent acidification of trans-Golgi in epithelial cells or CFTR-transfected fibroblasts (72) . Subsequent studies by several groups have all yielded the same general conclusion, that Golgi pH is primarily regulated by H ϩ pump and leak pathways rather than counterion conductance (7, 20, 69, 83) . These studies have been performed in a wide variety of cell types, including airway epithelial cells expressing ⌬F508-CFTR and corrected with wild-type CFTR (7).
DEFECTIVE PHAGOLYSOSOMAL ACIDIFICATION IN CF ALVEOLAR MACROPHAGES AS A CAUSE OF MACROPHAGE DYSFUNCTION
In 2006, Di and colleagues (16) reported the requirement of CFTR for the activity of alveolar macrophages, key protagonists of the innate immune system. Macrophages patrol the body and engulf pathogens in nascent organelles called phagosomes that subsequently mature into phagolysosomes having antimicrobial activities (15, 82, 84) . Di et al. (16) reported that alveolar macrophages from CFTR-null mice were unable to kill bacteria. Efficient antimicrobial activity within the macrophage phagolysosome requires a low pH of ϳ5. Di et al. (16) found that pH in phagolysosomes in alveolar macrophages from CFTR-null mice was ϳ2 pH units more alkaline than those from control mice (Fig. 3A) . They also found a defect in lysosomal acidification in CFTR-null alveolar macrophages, with pH ϳ6 in CF macrophages vs. ϳ4.5 in control macrophages, which was proposed, by a slow fusion mechanism, to account for the defect in phagolysosomal acidification. Although Di et al. (16) made no direct connection between CFTR mutations, phagolysosomal acidification in alveolar macrophages, and CF disease progression, the implication of their study was the involvement of defective alveolar macrophage function in the pathogenesis of CF lung disease (Refs. 11, 76, 78; Fig. 3B ).
Because of the important ramifications of the Di et al. (16) study for CF disease progression as well as technical concerns, we independently investigated the role of CFTR in phagolysosomal acidification in alveolar macrophages. A major technical concern was that the key observations reported by Di et al. (16) were generated using nonratiometric imaging methods and fluorescein-based probes with poor pH sensitivity [acid dissociation constant (pK a ) ϳ6.7] at the low pH in lysosomes and phagolysosomes. To measure the pH of mature phagolysosomes, a fluorescent pH indicator was synthesized consisting of Oregon Green 488 and tetramethylrhodamine conjugated to the phagocytic substrate zymosan ( Fig. 3C; Ref. 30 ). The pK a of Oregon Green 488 renders it pH-sensitive in the range of pH found in phagolysosomes, and pH-insensitive tetramethylrhodamine permits determination of pH by ratio imaging, such that the results do not depend on the extent of probe uptake. One of the tools used to investigate the role of CFTR in phagolysosomal acidification is pharmacological inhibition by CFTR inh -172, a potent, selective, and chemically stable small molecule inhibitor of CFTR that was discovered by highthroughput screening (49) . CFTR inh -172 inhibits CFTR chloride conductance by direct interaction with amino acids in the cytoplasmic domain of CFTR (6) so that it would effectively inhibit both plasma membrane and organellar CFTR. In contrast to Di et al. (16) , we found that phagolysosomal acidification was not altered by CFTR inhibition by CFTR inh -172 in macrophage cell lines (J774A.1), isolated murine alveolar macrophages, and isolated human alveolar macrophages (30) . Also, alveolar macrophages from CF mice acidified in an identical manner to those from control, non-CF mice (Fig. 3D) . Lysosomal acidification was found to be unimpaired as well, as measured using a dextran-conjugate containing Oregon Green 488 and tetramethylrhodamine. Finally, kinetic measurements of pH using a fluorescently labeled zymosan probe showed rapid phagolysosomal acidification, in agreement with a large body of data (30, 47, 48, 82, 84) but contrary to the results of Di et al. (16) . A recent study also concluded that that CFTR deletion did not alter lysosomal acidification in murine macrophages (43) . Together, these studies do not support the contention that CFTR mediates phagolysosomal acidification or maturation in alveolar macrophages.
DEFECTIVE LYSOSOMAL ACIDIFICATION IN CF AIRWAY EPITHELIAL CELLS AS A CAUSE OF CERAMIDE ACCUMULATION
Teichgräber and coworkers (79) recently reported a new pathological manifestation of CF with the potential to link CFTR mutation to lung disease. They reported that the sphingolipid ceramide was increased by 4-to 10-fold in respiratory tract epithelial cells, submucosal gland cells, and alveolar macrophages in murine models of CF and in airway epithelial cells from human CF subjects. Ceramide is a lipid signaling moiety that is induced by a variety of endogenous factors, including TNF-␣, Fas, and interferons, as well as exogenous factors such as chemotherapeutic agents, endotoxin, and UV/ ionizing radiation (33) . As such, various stress signals elevate ceramide concentration and can induce apoptosis and inflammation. In CF mice, reduction of ceramide levels by amitriptyline (an inhibitor of the ceramide-producing enzyme acid sphingomyelinase) or knockout of the acid sphingomyelinase gene reduced several key parameters of CF disease including airway inflammation, phagocyte recruitment, and susceptibility to infection by Pseudomonas aeruginosa. To relate defective CFTR function to ceramide accumulation, Teichgräber et al. (79) reported that lysosomal acidification in airway epithelial cells was CFTR-dependent, with pH ϳ6 in airway cells from CF mice vs. ϳ5 in cells from control mice. Alkalinization of lysosomes in CF epithelial cells was proposed to impair the activity of ceramide-metabolizing enzymes leading to ceramide accumulation (Fig. 4A) . Defective lysosomal acidification was thus proposed to be the critical link between CFTR mutation, ceramide accumulation, and CF pathology (Fig. 4B) . Although a compelling study, there is conflicting evidence about whether ceramide is increased in CF. Guilbault and coworkers (27, 28) have reported decreased ceramide in CF humans and mice. A recent study using cell culture models reported that CFTR dysfunction increased sphingolipid synthesis and altered cellular ceramide profiles but did not change overall ceramide levels (32).
We (31) reinvestigated the central mechanistic observation of defective lysosomal acidification in CF epithelia proposed by Teichgräber et al. (79) . They (79) measured lysosomal pH using LysoSensor Green (commercially available from Invitrogen), a weak base that accumulates in acidic organelles in response to pH gradients and for which fluorescence is increased on protonation. This pH-sensing mechanism, and the nonratioable nature of LysoSensor Green, precludes quantitative measurement of lysosomal pH, as we (31) found experimentally. To measure lysosomal pH directly, a pH sensor was synthesized consisting of Oregon Green 488 and tetramethylrhodamine conjugated to dextran, which is ratioable and pHsensitive at the low pH in lysosomes. This probe was "pulse"-loaded into cells by fluid-phase endocytosis and trafficked to lysosomes during a prolonged "chase" period. Using the CFTR inhibitor CFTR inh -172, we found no evidence for CFTR involvement in lysosomal acidification in epithelial cell lines, freshly isolated murine tracheal and human nasal epithelial cells, and cultured human nasal and bronchial epithelial cells (Fig. 4C) . Furthermore, lysosomal acidification was not impaired in freshly isolated nasal epithelial cells from CF subjects, tracheal epithelial cells from CF mice, and well-differentiated primary cultures of CF human nasal epithelial cells (Fig. 4C) . These findings provided direct evidence against the conclusions of Teichgräber et al. (79) that lysosomal acidification is CFTR-dependent and impaired in CF, indicating that defective lysosomal acidification cannot account for altered ceramide levels in CF.
ORGANELLAR HYPERACIDIFICATION IN CF CELLS
An opposing hypothesis relating organellar acidification to CF disease has been proposed by Deretic and coworkers (62) (63) (64) . They reported hyperacidification of cellubrevin-positive endosomes (recycling endosomes) by ϳ0.5 pH units in bronchial and tracheal epithelial cell lines derived from CF patients vs. the same cell lines after correction by transfection with wild-type CFTR (pH ϳ6.1 in CF vs. ϳ6.6 in control cells; Ref. 64) . They also reported hyperacidic Golgi in CF airway epithelial cells vs. CFTR-corrected cells (ϳpH 6.2 in CF vs. ϳ6.7; Ref. 62). Deretic and colleagues postulated that CFTR mutation, and consequent CFTR mislocalization, leads to unregulated epithelial sodium channel (ENaC)-mediated sodium efflux from the organellar lumen (equivalent to chloride entry) resulting in lumen hyperacidification (Fig. 5 ). In accord with this hypothesis, evidence was reported for endosomal pH correction (alkalinization) after amiloride treatment in immortalized cell lines (64) . The same group (63) further reported that inhibition of ENaC through elevation of cGMP with nitric oxide donors, guanylate cyclase agonists, or inhibition of the cGMP-specific phosphodiesterase PDE5 also corrected endosomal pH in CF cell lines and primary CF lung epithelial cells.
Although the exact experiments of Deretic and colleagues have not been independently repeated, there are significant conceptual and technical concerns as well as conflicting data in similar systems. Organellar pH was measured in the Deretic et al. studies using pHluorin, a ratiometric GFP probe that can be genetically targeted to the lumen of specific organelles (53) . Although the pK a of this probe is appropriate to study pH in endosomes and the Golgi, the data presented showed low pH sensitivity as used, with only ϳ10% change in probe signal in the pH range (ϳ6.1 to 6.7) reported in CF vs. non-CF organelles, such that the reported differences appear to be within the experimental noise (Fig. 1 in Refs. 62 and 64). Although ENaC was postulated to be responsible for Golgi hyperacidification (62) , data to support this contention, such as amiloride effect on Golgi alkalinization, are notably absent. Similarly, although evidence is reported to indicate that cGMP elevation alkalinizes endosomes in primary CF lung epithelial cells (63), endosomal pH is not reported in control primary cells for comparison. As discussed above, Golgi pH regulation is primarily governed by proton pump and leak pathways, with no evidence for involvement of Na ϩ (7, 20, 69, 83) . Furthermore, Chandy et al. (7) reported conflicting data using identical cell lines to those in the Deretic et al. studies, with only a minor difference in Golgi pH of ϳ0.2 pH and no effect of amiloride on Golgi pH in CF cells. We note also that although sodium hyperabsorption in the CF airways is a generally accepted concept (4), the evidence for direct ENaC regulation by CFTR, as would be required here, remains controversial (57) . Direct evidence for ENaC expression and function on organellar membranes is lacking as well. A clear answer on whether ENaC-dependent organellar hyperacidification occurs in CF will await further independent evaluation but seems unlikely.
ROLE OF NON-CFTR CHLORIDE CHANNELS IN ORGANELLAR ACIDIFICATION
As discussed above, there is a substantial body of evidence against the involvement of CFTR in organellar acidification. Recent studies suggest that members of the ClC family of chloride channels are involved in endolysosomal acidification (8, 38 -40) . Nine mammalian ClC channels have been cloned that reside in either the plasma membrane (ClC-1, -2, -Ka, and -Kb) or in intracellular organelles (ClC-3 to -7). ClC-3, -4, and -7 show relatively broad tissue distributions, whereas ClC-5 is restricted to the kidney and intestine, and ClC-6 to the nervous system. ClC-3 through -6 are found in endosomes, with ClC-3 also present in synaptic vesicles, and ClC-7 is localized in lysosomes, late endosomes, and the specialized resorption lacuna of osteoclasts.
Direct measurements of organellar pH and chloride concentration, the latter made using probes conjugated to the chloridesensitive fluorescent probe 10,10Ј-bis(3-carboxypropyl)-9,9Ј-bisacridinium dinitrate (BAC; Refs. 73, 74), provided evidence for the involvement of ClCs in endosomal acidification (34, 35) . Early and late endosomes in primary hepatocytes isolated from ClC-3 knockout mice were ϳ0.5 pH units more alkaline and contained ϳ15 mM less chloride than in control cells (35) . Overexpression of ClC-3 in fibroblasts also increased the rate of acidification and chloride accumulation in early and late endosomes (35) . ClC-5 was demonstrated to mediate early endosomal, but not late endosomal, acidification and chloride accumulation in primary cultures of proximal tubule cells (34) . However, the nonspecific chloride channel blocker 5-nitro-2-(3-phenylpropylamino)benzoic acid (NPPB) further inhibited endosomal acidification in ClC-5 knockout cells, suggesting the presence of additional chloride conductance pathways in early endosomes in this cell type. Studies using vesicles isolated from primary cells have also provided evidence that deletion of ClC channels limits the counterion conductance of endosomes in hepatocytes (ClC-3; Ref. 35) , kidney cells (ClC-5; Ref. 29) , and synaptic vesicles in neurons (ClC-3; Ref. 77) . RNA interference (RNAi)-mediated knockdown of ClC-7 in cell cultures was shown to inhibit lysosomal acidification, albeit in a semiquantitative manner involving measurement of LysoTracker uptake (25) . Finally, ClC-7 knockout results in the absence of acidic resorption lacunas, which are "extracellular lysosomes" that form between osteoclasts and bone (42) , producing a mouse model of osteopetrosis.
However, several critical issues remain to be resolved regarding the function of ClC chloride channels in endolysosomal acidification. First, in contrast to the findings of Graves et al. (25) , lysosomal acidification in neurons and fibroblasts, measured by ratio imaging of cells with Oregon Green 488-dextran-labeled lysosomes was not impaired by ClC-7 knockout or in gray-lethal mice (which lack Ostm1, the essential ␤-subunit of ClC-7; Refs. 41, 44) . Second, the electrophysiological characteristics of ClCs in organelles are not known nor is the H ϩ -to-Cl Ϫ stoichiometry or precise driving forces for luminal acidification. It is presumed that the interior-positive organellar potential drives inward negative current with Cl Ϫ entry and H ϩ exit, as shown in Fig. 1 . In expression systems, including Xenopus oocytes and human embryonic kidney 293 cells in which intracellular ClCs traffic to the plasma membrane, both ClC-5 (70) and ClC-3 (55) demonstrate outwardly rectifying characteristics, that is, channels open preferentially under depolarizing conditions. In depolarized cells, ClC-4 and ClC-5 demonstrate coupled transport of protons out of the cell and chloride ions into the cell (61, 70) . As such, the directionality of proton and chloride transport by ClC channels in organellar membranes is consistent with charge neutralization, albeit with the ClC channel operating at a membrane potential where its predicted conductance would be very small. If the H ϩ -to-Cl Ϫ stoichiometry is ϳ1:2 (25, 61, 70) , then a single ClC turnover (3 net inward negative charges) can support entry of 3 protons via the vacuolar proton pump. Finally, charge neutralization using ClC channels confers an additional metabolic burden on cells as protons are necessarily extruded by the ClC antiport activity. These issues will require further investigation before concluding with confidence that ClCs play a major role in organellar acidification by an H ϩ -to-Cl Ϫ exchange mechanism.
An elegant genetic approach recently identified an anion channel called Golgi pH regulator (GPHR) as a key determinant of Golgi acidification (51) . To identify GPHR, Maeda and colleagues (51) screened chemically mutagenized cells for defective plasma membrane delivery of a reporter protein that is retained in the endoplasmic reticulum at nonpermissive temperatures but trafficked on temperature reduction. Deletion of GPHR reduced Golgi acidification (pH ϳ6.7 in mutant cells vs. ϳ6.3 in control cells) and produced Golgi fragmentation and impaired protein glycosylation. In reconstituted planar lipid bilayers, GPHR formed DIDS-inhibited, high-conductance anion channels. Although GPHR was shown to be ubiquitous, its role in controlling Golgi pH in airway epithelia, and other CFTR-expressing cells, is currently unknown.
ROLE OF CFTR IN NEUTROPHIL ACTIVITY
Although not directly related to organellar acidification, a role for CFTR has been proposed in chloride entry into the phagosome of neutrophils. Like macrophages, neutrophils are phagocytes that engulf and destroy pathogens (15, 45) . The antimicrobial mechanism of neutrophils is very different from that of macrophages: neutrophils rely on chemical agents to kill pathogens, and, despite H ϩ -ATPase-mediated proton entry into the phagosomal lumen, significant acidification of the neutrophil phagosome does not occur (37, 45) . Instead, protons are consumed to generate the antimicrobial compounds hydrogen peroxide (H 2 O 2 ) and hypochlorous acid (HOCl) that are derived from superoxide ions (O 2 Ϫ ) produced by NADPH oxidase (Fig. 6) . A significant membrane potential (believed to be ϳ100 mV interior-negative) develops across the limiting phagosomal membrane during maturation in neutrophils because NADPH oxidase pumps electrons into the lumen and liberates protons in the cytoplasm. As such, a proton (14) or potassium (1, 66) conductance pathway has been proposed to dissipate the negative charge. The identity of this putative channel and its role in antimicrobial activity remains controversial (12, 13, 45, 71) . However, the BK Ca (maxi-K ϩ ) channel proposed by Segal and colleagues (1, 66) to be critical for neutrophil activity was subsequently shown to be absent in phagocytes and thus cannot contribute to neutrophil activity (19, 21) .
Painter and colleagues (59, 60) reported that CFTR is the conduit for chloride entry into the neutrophil phagosome and that this pathway is critical for HOCl production and neutrophil function. This interesting mechanism will require verification, however, as Di et al. (16) reported conflicting data that CFTR is not expressed in neutrophils and that CFTR deletion did not alter bacterial killing by neutrophils. Also, it has been suggested that ClC-3 may be the channel responsible for neutrophil phagosome function, as there is increased prevalence of sepsis in ClC-3 knockout mice following intravascular procedures, and ClC-3 was shown to be localized in phagosomes and important for neutrophil activity (54, 55) . Whether CFTR is present and functional in neutrophils thus remains unclear.
CONCLUDING REMARKS
Although defective organellar acidification in CF offers a potentially attractive mechanism to account for the multiple abnormalities in CF at the cell and organ levels, the published data fail to provide credible evidence for CFTR-dependent organellar acidification or for abnormal organellar pH in CF. Chloride channels of the ClC family and newer candidates such as GPHR, and perhaps, in some cell types, potassium channels, may provide the counterion shunt pathway during organellar acidification. Further consideration is also warranted in exploring the role of proton leak pathways and proton/cation exchangers, such as intracellular NHEs, in regulating organellar pH. With regard to CF pathogenesis, the crucial link between CFTR mutations and CF lung disease more likely resides at the cell plasma membrane than within cells. Failure of CFTRdependent fluid secretion by airway submucosal gland and surface airway epithelial cells might produce a hyperviscous, hyperacidic ASL with consequent impairment in mucociliary clearance and bacterial killing in CF.
NOTE ADDED IN PROOF
Barriere and colleagues recently reported a comprehensive study on the role of CFTR in endocytic/phagocytic organellar acidification [48th Annual Meeting of the American Society for Cell Biology, San Francisco, CA (December 13-17, 2008), T-L56, and Gergely L. Lukacs, personal communication] . Based on measurements in multiple cell types and organelles, they concluded that organellar acidification is CFTR-independent. Also, in agreement with our studies (30) and in direct contradiction to Di et al. (16) , no evidence was found for CFTR involvement in phagosomal acidification in macrophage cell lines and primary alveolar/peritoneal macrophages from wildtype and CFTR knockout mice. Also, recently, Schenck and colleagues (70a) reported that vesicular glutamate transporter 1 (VGLUT1), and not ClC as previously reported (77) , provides the predominant chloride conductance pathway in synaptic vesicles.
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